Distribution and elimination of intravenously injected urinary trypsin inhibitor

BM Jönsson-Berling, K Ohlsson - Scandinavian journal of clinical …, 1991 - Taylor & Francis
BM Jönsson-Berling, K Ohlsson
Scandinavian journal of clinical and laboratory investigation, 1991Taylor & Francis
Elimination of human urinary trypsin inhibitor (UTI) after intravenous injection of l25I-labelled
UTI was followed by serial plasma and urine samples in three male volunteers. The plasma
half-life of l23IUTI during 0-3 h after injection was 33 min and during the following 4 hours
the half-life was 2 hours. Free, biologically active inhibitor was found in the urine during the
first four hours after injection. Most of the radioactivity in the urine, however, corresponded to
free l25I probably released during the degradation of UTI in the kidney. The distribution of …
Elimination of human urinary trypsin inhibitor (UTI) after intravenous injection of l25I-labelled UTI was followed by serial plasma and urine samples in three male volunteers. The plasma half-life of l23IUTI during 0-3 h after injection was 33 min and during the following 4 hours the half-life was 2 hours. Free, biologically active inhibitor was found in the urine during the first four hours after injection. Most of the radioactivity in the urine, however, corresponded to free l25I probably released during the degradation of UTI in the kidney. The distribution of UTI was studied after injection of l25IUTI in rats by measurement of radioactivity in excised organs. Fifteen min after the injection 44% of the radioactivity was found in the kidneys and 9% in the liver, implying that the kidneys are the primary site of UTI metabolism.
Taylor & Francis Online